Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Zevalin

(ZEH-vuh-lin)
A drug used to treat adults with certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Zevalin contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells and some types of lymphoma cells. It also contains the compound tiuxetan, which allows certain radioactive substances to be attached to the monoclonal antibody. This may help kill cancer cells. Zevalin is a type of monoclonal antibody and a type of immunoconjugate. Also called ibritumomab tiuxetan.
Search NCI's Dictionary of Cancer Terms